Status:
COMPLETED
Interdisciplinary Case-Control Study of Bladder Cancer in Spain
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Bladder Cancer
Eligibility:
All Genders
21-80 years
Brief Summary
The incidence rate of bladder cancer in the Barcelona area of Spain is almost identical to that of the U.S. Cigarette smoking has been identified as the most significant risk factor for bladder cancer...
Detailed Description
The incidence rate of bladder cancer in the Barcelona area of Spain is almost identical to that of the U.S. Cigarette smoking has been identified as the most significant risk factor for bladder cancer...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- All histologically confirmed cases of carcinoma of the bladder including carcinoma in situ at the 21 centers.
Exclusion
Key Trial Info
Start Date :
September 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 14 2020
Estimated Enrollment :
2925 Patients enrolled
Trial Details
Trial ID
NCT00341861
Start Date
September 1 1998
End Date
October 14 2020
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Municipal d'Investigacio Medica
Barcelona, Spain